AskBio Inc. is a fully integrated gene therapy company and a subsidiary of Bayer AG, focused on developing life-saving medicines that transform lives. With a diverse portfolio of clinical programs targeting neuromuscular, central nervous system, cardiovascular, and metabolic diseases, AskBio is at the forefront of innovative therapeutics, including investigational treatments for conditions such as congestive heart failure and Parkinson’s disease. The company leverages its proprietary gene therapy platform, Pro10™, and has established a strong presence with headquarters in Research Triangle Park, North Carolina, and Edinburgh, Scotland. Committed to pioneering science and advancing clinical outcomes, AskBio fosters a collaborative and responsible work environment, aiming to make gene therapies accessible to those in need.